Chem Genes: n-Lorem Foundation, ChemGenes Announce Collaboration to Support Manufacturing of Individualized Treatments for Patients with Ultra-Rare Diseases

n-Lorem Foundation, a nonprofit organization that provides free, lifetime supplies of individualized RNA-targeted medicines to patients living with ultra-rare diseases, today announced a new partnership with ChemGenes Corporation, a biotechnology company providing unparalleled expertise in the field of DNA/RNA synthesis for more than 40 years.